Brief: EyePoint Pharmaceuticals Q4 basic EPS USD -0.33
07/03/2024 12:08
Mar 7 (Reuters) - EyePoint Pharmaceuticals Q4 basic EPS USD -0.33. * Q4 net income USD -14.016 million * Q4 operating income USD -16.354 million * Q4 product sales USD 749 thousand * Q4 operating expenses USD 30.382 million
Recent news on EyePoint
See all newsUS RESEARCH ROUNDUP-Axon Enterprise, Williams-Sonoma, Xcel Energy
US STOCKS ON THE MOVE-CoreWeave, Moderna, Datadog
U.S. STOCKS ON THE MOVE-Amazon, CoreWeave, Moderna
U.S. STOCKS ON THE MOVE-Centrus Energy, Disc Medicine, Crypto
EyePoint to halve workforce after experimental drug fails second late-stage trial (updated)